Natac Natural Ingredients Statistics
Total Valuation
BME:NAT has a market cap or net worth of EUR 243.97 million. The enterprise value is 313.47 million.
| Market Cap | 243.97M |
| Enterprise Value | 313.47M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:NAT has 431.80 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 431.80M |
| Shares Outstanding | 431.80M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.24% |
| Float | n/a |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 56.50 |
| PS Ratio | 5.30 |
| PB Ratio | 6.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 49.39 |
| P/OCF Ratio | 20.38 |
| PEG Ratio | 1.64 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 52.29, with an EV/FCF ratio of 63.46.
| EV / Earnings | n/a |
| EV / Sales | 6.81 |
| EV / EBITDA | 52.29 |
| EV / EBIT | 124.65 |
| EV / FCF | 63.46 |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 1.80.
| Current Ratio | 0.48 |
| Quick Ratio | 0.21 |
| Debt / Equity | 1.80 |
| Debt / EBITDA | 11.74 |
| Debt / FCF | 14.25 |
| Interest Coverage | 0.54 |
Financial Efficiency
Return on equity (ROE) is -0.34% and return on invested capital (ROIC) is -0.29%.
| Return on Equity (ROE) | -0.34% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | -0.29% |
| Return on Capital Employed (ROCE) | 3.26% |
| Weighted Average Cost of Capital (WACC) | 0.88% |
| Revenue Per Employee | 254,418 |
| Profits Per Employee | -726 |
| Employee Count | 181 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 0.80 |
Taxes
In the past 12 months, BME:NAT has paid 1.16 million in taxes.
| Income Tax | 1.16M |
| Effective Tax Rate | 112.74% |
Stock Price Statistics
The stock price has decreased by -28.48% in the last 52 weeks. The beta is -0.52, so BME:NAT's price volatility has been lower than the market average.
| Beta (5Y) | -0.52 |
| 52-Week Price Change | -28.48% |
| 50-Day Moving Average | 0.57 |
| 200-Day Moving Average | 0.63 |
| Relative Strength Index (RSI) | 44.98 |
| Average Volume (20 Days) | 27,305 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NAT had revenue of EUR 46.05 million and -131,332 in losses. Loss per share was -0.00.
| Revenue | 46.05M |
| Gross Profit | 31.77M |
| Operating Income | 2.51M |
| Pretax Income | 1.03M |
| Net Income | -131,332 |
| EBITDA | 5.75M |
| EBIT | 2.51M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 886,487 in cash and 70.39 million in debt, with a net cash position of -69.50 million or -0.16 per share.
| Cash & Cash Equivalents | 886,487 |
| Total Debt | 70.39M |
| Net Cash | -69.50M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | 39.13M |
| Book Value Per Share | 0.09 |
| Working Capital | -31.40M |
Cash Flow
In the last 12 months, operating cash flow was 11.97 million and capital expenditures -7.03 million, giving a free cash flow of 4.94 million.
| Operating Cash Flow | 11.97M |
| Capital Expenditures | -7.03M |
| Depreciation & Amortization | 7.19M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.94M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 68.98%, with operating and profit margins of 5.46% and -0.29%.
| Gross Margin | 68.98% |
| Operating Margin | 5.46% |
| Pretax Margin | 2.24% |
| Profit Margin | -0.29% |
| EBITDA Margin | 12.49% |
| EBIT Margin | 5.46% |
| FCF Margin | 10.73% |
Dividends & Yields
BME:NAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -0.05% |
| FCF Yield | 2.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |